Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,967 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

NCT01221298

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +11 more
Locations
  • Site Reference ID/Investigator# 41128 Los Angeles, California, United States
  • Site Reference ID/Investigator# 42262 Chicago, Illinois, United States
  • Site Reference ID/Investigator# 41127 San Antonio, Texas, United States
  • Site Reference ID/Investigator# 43182 Seattle, Washington, United States
View Trial Details
Completed

A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072

NCT01074008

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +11 more
Locations
  • Site Reference ID/Investigator# 23392 Phoenix, Arizona, United States
  • Site Reference ID/Investigator# 23370 Anaheim, California, United States
  • Site Reference ID/Investigator# 23387 La Jolla, California, United States
  • Site Reference ID/Investigator# 23388 Los Angeles, California, United States
View all 26 locations
View Trial Details
Completed

A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies

NCT00726882

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Site Reference ID/Investigator# 17665 Anaheim, California, United States
  • Site Reference ID/Investigator# 17367 Los Angeles, California, United States
  • Site Reference ID/Investigator# 17672 Los Angeles, California, United States
  • Site Reference ID/Investigator# 10381 Orlando, Florida, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

NCT01306617

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +10 more
Locations
  • Site Reference ID/Investigator# 48263 Los Angeles, California, United States
  • Site Reference ID/Investigator# 48264 Aurora, Colorado, United States
  • Site Reference ID/Investigator# 51282 Gainesville, Florida, United States
  • Site Reference ID/Investigator# 50425 Springfield, Massachusetts, United States
View Trial Details
Completed

Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy

NCT01405027

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations
  • California Liver Institute Beverly Hills, California, United States
  • Samuel Burstein, MD Calabasas, California, United States
  • William Katkov, MD Santa Monica, California, United States
  • Sutha Sachar, MD Torrance, California, United States
View all 43 locations
View Trial Details

Related conditions